Last update:

HIV & AIDS news

HIV & AIDS

Tuberculosis vulnerability of people with HIV: Viral protein implicated

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 ...

HIV & AIDS

An HIV outbreak in Maine shows the risk of Trump's crackdown on homelessness and drug use

Penobscot County, Maine, is grappling with the largest HIV outbreak in the state's history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years. That's seven times the typical ...

HIV & AIDS

How HIV uses T cells to hide in the gut

Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy and reducing transmission. But one major challenge has so far prevented researchers from developing ...

Genetics

Comorbidities in HIV: Big data study reveals molecular links

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine (CiiM) investigated this ...

HIV & AIDS

Setback in the fight against pediatric HIV

For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where the rate of infection exceeded 30% in some areas of the country in the 1990s.

Medications

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

HIV & AIDS

Pediatricians can play key role in HIV testing, prophylaxis

(HealthDay)—In a clinical report published online Dec. 20 in Pediatrics, recommendations are presented for addressing HIV testing and preexposure and postexposure HIV prophylaxis in adolescents and young adults.

Medical research

Discovery of I-shaped antibody opens new avenue to HIV vaccine

About 38 million people worldwide are living with AIDS. Pharmaceutical treatments can keep the disease in check, but a vaccine remains elusive despite decades of concerted effort. However, a recent discovery at the Duke Human ...

HIV & AIDS

Study shows how HIV copies itself in the body

HIV replication in the human body requires that specific viral RNAs be packaged into progeny virus particles. A new study has found how a small difference in the RNA sequence can allow the viral RNA to be packaged for replication, ...

HIV & AIDS

Impact of HIV virus on COVID-19 disease

A new study found that during the early months of the COVID-19 pandemic people living with HIV were less likely to die from COVID than persons without HIV. Hospitalized patients with HIV and COVID were less likely to require ...

HIV & AIDS

Dementia more common in adults with HIV

(HealthDay)—People older than 50 years with HIV are more likely to have dementia than people without HIV, according to a study published online Nov. 24 in AIDS.

HIV & AIDS

Experimental mRNA vaccine for HIV shows promise in animals

An experimental HIV vaccine based on mRNA—the same technology used in two highly successful COVID-19 vaccines—has shown promise in experiments in mice and monkeys, according to a study published Thursday in Nature Medicine.

HIV & AIDS

Experimental mRNA HIV vaccine safe, shows promise in animals

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of ...

HIV & AIDS

Hydrogen sulphide gas suppresses HIV infection

Researchers at the Indian Institute of Science (IISc) and their collaborators have identified a key role played by hydrogen sulfide (H2S) gas in suppressing the human immunodeficiency virus (HIV). Increased H2S was found ...

HIV & AIDS

HIV infections drop, but COVID hampers fight: WHO

HIV infection rates in Africa have decreased markedly, but the continent is still behind set targets, with efforts slowed by the COVID-19 pandemic, the World Health Organization said Tuesday.